OR34 Testosterone Replacement Therapy: Risks and Benefits

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Reproductive Endocrinology-Clinical/Translational
Saturday, March 7, 2015: 11:30 AM-1:00 PM
Room 6A (San Diego Convention Center)
**This session is NOT eligible for CME credit**

Chairs:
Joel Stephen Finkelstein, MD, MS, Massachusetts General Hospital, Boston, MA and To Be Determined

Disclosures:
JSF: Principal Investigator, AbbVie. Disclosure Not Provided: FCWW, BR
11:30 AM
Elaine W. Yu, MD, MSc1, Hang Lee, PhD2, Sherri-Ann M Burnett-Bowie, MD, MPH1, Sarah C Hirsch, BS3, Gabriela Abrishamian-Garcia, BA3, Lawrence F Borges, MD3, David W. Goldstein, BS3, Alex P Taylor, BA3, Kendra Elizabeth Wulczyn4, Allan F Moore, MD5 and Joel Stephen Finkelstein, MD, MS1, (1)Endocrine Unit, Massachusetts General Hospital, Boston, MA
(2)Biostatistics Center, Massachusetts General Hospital, Boston, MA
(3)Massachusetts General Hospital
(4)Massachusetts General Hospital, Philadelphia, PA
(5)Massachusetts General Hospital, PA
11:45 AM
Hu Li, MBBS, PhD1, Nancy L Ostrowski, PhD1, Karin Benoit, BS1, Wei Wang, MS2 and Stephen P Motsko, PharmD1, (1)Global Patient Safety, Eli Lilly and Company, Indianapolis, IN
(2)Biostatistics, Eli Lilly and Company, Indianapolis, IN
12:00 PM
Reshmi Srinath, MD1, Rebecca Gottesman, MD PhD2, Kathryn A Carson, ScM3, Sherita Hill Golden, MD, MHS4 and Adrian S Dobs, MD, MHS4, (1)Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD
(2)Cerebrovascular Neurology, Johns Hopkins School of Medicine, Baltimore, MD
(3)Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
(4)Endocrinology Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD
12:15 PM
Salim Janmohamed, BSc MBBS (Hons) FRCP, Metabolic Pathways and Cardiovascular Therapy Area Unit, GSK R&D Ltd, Uxbridge, United Kingdom, Greg Cicconetti, PhD, Clinical Statistics, GSK R&D Ltd, King of Prussia, PA, Carol E Koro, PhD, Worldwide Epidemiology, GSK R&D Ltd, Collegeville, PA, Richard V Clark, MD, PhD, Muscle Metab DPU, Metab Pathways, GSK R&D Ltd, Research Triangle Pk, NC and Elizabeth Tarka, MD, Metabolic Pathways and Cardiovascular Therapy Area Unit, GSK R&D Ltd, King of Prussia, PA
12:30 PM
Christina Wang1, Anthony DelConte, MD2, Jed C. Kaminetsky, MD3, Martin M. Miner, MD4, Pavan Rajendra Yadav5, Srinivasan Venkateshwaran6, Nachiappan Chidambaram6, Satish Nachaegari6, Mahesh Patel6 and Adrian S Dobs, MD, MHS7, (1)Medicine, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, CA
(2)Saint Joseph’s University, Philadelphia, PA
(3)University Urology Associates, New York, NY
(4)Brown University and the Miriam Hospital, Providence, RI
(5)Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, CA
(6)Lipocine, Inc., Salt Lake City, UT
(7)Johns Hopkins University School of Medicine, Baltimore, MD
12:45 PM
Arthi Thirumalai1, Lori Cooper2, John K. Amory, MD, MPH3, Jonathan L Wright, MD, MS, FACS4, Alvin M. Matsumoto, MD5, Daniel W Lin, MD4, Brett Marck6 and Stephanie T. Page, MD, PhD7, (1)Medicine/Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA
(2)Endocrinology, The Polyclinic, Seattle, WA
(3)Univ Washington, Seattle, WA
(4)Urology, University of Washington, Seattle, WA
(5)VA Puget Sound Health Care System, Seattle, WA
(6)VA Puget Sound, Seattle, WA
(7)Department of Medicine, University of Washington and Harborview Medical Center, Seattle, WA